Health / Medical Topics

    fluorine F 18 FEQA

    Pronunciation

    Definition 1

    A radioactive substance being studied in positron emission tomography (PET) imaging to detect cancer and to monitor the response of some types of cancer to treatment. Fluorine F 18 FEQA attaches to the epidermal growth factor receptor (EGFR) found on the surface of some tumor cells. It is a type of radiopharmaceutical. (NCI Dictionary)

    Definition 2

    The anilinoquinazoline derivative FEQA radiolabeled with the positron-emitting radioisotope fluorine F 18 with epidermal growth factor receptor (EGFR) binding and radioisotopic activities. Fluorine F 18 FEQA irreversibly binds to EGFR, allowing imaging of EGFR-positive tumor cells with positron emission tomography (PET). (NCI Thesaurus)




    YOU MAY ALSO LIKE

    A radioconjugate containing a derivative of the androgen testosterone, 16-beta-fluoro-5-alpha-dihydrotestosterone (FDHT), labeled with the radioisotope fluorine F18 (18F-FDHT), with potential use as…
    A substance being studied in positron emission tomography (PET) imaging to detect tumor hypoxia (a low level of oxygen in the…
    A radioconjugate containing a low molecular weight tracer, DCFBC, specific for prostate-specific membrane antigen (PSMA) and labeled with the positron-emitting isotope fluorine…
    A radioconjugate comprised of the synthetic pyrimidine analogue 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)thymine (d-FMAU) labeled with the radioisotope fluorine F 18 (18F-d-FMAU), that can potentially be…
    A triazole containing pentapeptide labeled with the positron-emitting isotope fluorine F 18, used as a tracer for positron emitting tomography (PET)…
    A radioconjugate composed of choline labeled with the positron-emitting isotope fluorine F 18, with potential tumor tracer activity using positron emission tomography…

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact